STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #209 by analyst upside · 2026-09-14
IXHL
Incannex Healthcare Inc.
Healthcare · Market Cap $39M · P/E 0x
ANALYST PRICE TARGET
+458.6%
implied upside to consensus target
Current Price $3.26
Consensus Target $18.21
Bull Target $18.21
Bear Target $18.21
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $2.49
52-Week High $20.31
YTD Return -72.1%
FUNDAMENTALS
Market Cap $39M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-16.62
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $2.49
52-Week High $20.31
Current Price $3.26
Bear Target $18.21
Bull Target $18.21
● Now $3.26 ● Target $18.21
TRADING DATA
Avg Volume 151K
YTD Return -72.1%
Analyst Count 1
Consensus Buy
Upside to Target +458.6%
Last Updated 2026-09-14

ANALYST SUMMARY

Incannex Healthcare Inc. (IXHL) is currently trading at $3.26 with a Wall Street consensus price target of $18.21, implying potential upside of 458.6% over the next 12 months. 1 analysts currently cover IXHL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.21, while the most cautious has a target of $18.21.

IXHL operates in the Healthcare sector with a market capitalisation of $39M. The stock is down 72.1% year-to-date and is currently trading near the lower end of its 52-week range of $2.49 – $20.31.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for IXHL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Alliance Global Partners ● Initiated
Buy 2026-06-08 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →